Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02763683 · ClinicalTrials.gov registry record
Investigations of Dementia in Parkinson Disease
A clinical trial of Parkinsons, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 320
- Enrollment target
- 1
- Study location
NCT02763683 is a study of Parkinsons that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 320 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02763683, a study of Parkinsons, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify individuals with PD who are at risk of developing dementia, and to distinguish the underlying cause of dementia.
Conditions Studied
Interventions
- RADIATION PiB and VAT
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2016-06 |
| Est. Completion | 2030-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02763683
The ClinicalTrials.gov registry entry for NCT02763683 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinsons appearing as the primary indexed condition, and to 1 intervention - of which PiB and VAT is the first listed.
NCT02763683 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02763683 about?
NCT02763683 is a clinical study titled "Investigations of Dementia in Parkinson Disease". The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be able to identify in...
What is the current status of trial NCT02763683?
This trial is currently recruiting. The enrollment target is 320 participants. The study started on 2016-06. Estimated completion is 2030-03.
What conditions does trial NCT02763683 study?
This clinical trial studies the following conditions: Parkinsons.
What interventions are being tested in trial NCT02763683?
The interventions under investigation include: PiB and VAT (RADIATION).
Who is sponsoring clinical trial NCT02763683?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02763683 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.